{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T17:56:08Z","timestamp":1794938168818,"version":"4.9.1"},"reference-count":24,"publisher":"The Journal of Rheumatology","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Rheumatol"],"published-print":{"date-parts":[[2018,8]]},"abstract":"<jats:sec><jats:title>Objective.<\/jats:title><jats:p>The 2 pneumoproteins, KL-6 and CCL-18, are promising biomarkers in systemic sclerosis (SSc)-related interstitial lung disease (ILD). Our goal was to determine their predictive significance for forced vital capacity % (FVC%) decline within the first year of followup in patients with early SSc-ILD.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods.<\/jats:title><jats:p>Early SSc patients with imaging-verified ILD enrolled in the Genetics versus Environment in Scleroderma Outcome Study (GENISOS) cohort were included. Annualized rate of change in FVC% based on the baseline and followup measurement within 12\u201318 months was used as the surrogate outcomes for ILD progression.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results.<\/jats:title><jats:p>Eighty-two early SSc-ILD patients with mean disease duration of 2.3 years were investigated. FVC% change ranged from \u221223% to 38%. Baseline KL-6 levels were higher in patients than healthy controls (p &lt; 0.0001). Higher KL-6 levels were predictive of faster FVC% decline at the 1-year followup (r = \u22120.23, p = 0.037). Upon categorizing KL-6 using a previously published cutoff of 1273 U\/ml, its predictive significance remained in the univariable model (b = \u22120.07, p = 0.01), indicating that patients with positive KL-6 had on average 7% more decline in annualized percent change of FVC%. Moreover, KL-6 remained an independent predictor after adjustment for sex, disease type, anti-Scl-70, and immunosuppressive treatment status in multivariable models. Although CCL-18 was higher in patients than controls (p &lt; 0.001), its levels did not predict FVC decline rate (p = 0.458).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion.<\/jats:title><jats:p>KL-6 but not CCL-18 is predictive of early SSc-ILD progression. KL-6 is a promising pneumoprotein that can contribute to SSc-ILD clinical trial enrichment.<\/jats:p><\/jats:sec>","DOI":"10.3899\/jrheum.170518","type":"journal-article","created":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T11:29:46Z","timestamp":1530444586000},"page":"1153-1158","source":"Crossref","is-referenced-by-count":80,"title":["KL-6 But Not CCL-18 Is a Predictor of Early Progression in Systemic Sclerosis-related Interstitial Lung Disease"],"prefix":"10.3899","volume":"45","author":[{"given":"Gloria A.","family":"Salazar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masataka","family":"Kuwana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minghua","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa M.","family":"Estrada-Y-Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Ying","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio","family":"Charles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maureen D.","family":"Mayes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shervin","family":"Assassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2262","published-online":{"date-parts":[[2018,7,1]]},"reference":[{"key":"2018112909385360000_45.8.1153.1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2006.066068"},{"key":"2018112909385360000_45.8.1153.2","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.160339"},{"key":"2018112909385360000_45.8.1153.3","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1002\/art.38288","article-title":"Association of interferon- and transforming growth factor beta-regulated genes and macrophage activation with systemic sclerosis-related progressive lung fibrosis","volume":"66","author":"Christmann","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"2018112909385360000_45.8.1153.4","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.chest.2016.03.004","article-title":"High level of chemokine CCL 18 is associated with pulmonary function deterioration, lung fibrosis progression, and reduced survival in systemic sclerosis","volume":"150","author":"Hoffmann-Vold","year":"2016","journal-title":"Chest"},{"key":"2018112909385360000_45.8.1153.5","doi-asserted-by":"publisher","DOI":"10.1002\/art.24734"},{"key":"2018112909385360000_45.8.1153.6","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-204424"},{"key":"2018112909385360000_45.8.1153.7","unstructured":"Sekisui Diagnostics. Nanopia KL-6 Reagent. [Internet. Accessed May 17, 2018.] Available from: www.sekisuidiagnostics.com\/writable\/product_documents\/files\/kl-6reagenten_02.pdf"},{"key":"2018112909385360000_45.8.1153.8","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.159.1.9712108"},{"key":"2018112909385360000_45.8.1153.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.resinv.2012.02.001"},{"key":"2018112909385360000_45.8.1153.10","first-page":"653","article-title":"[Establishment of reference intervals and cut-off value by an enzyme immunoassay for KL-6 antigen, a new marker for interstitial pneumonia.]","volume":"44","author":"Kobayashi","year":"1996","journal-title":"Rinsho Byori"},{"key":"2018112909385360000_45.8.1153.11","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s10067-015-3167-8","article-title":"Association of serum KL-6 levels with interstitial lung disease in patients with connective tissue disease: a cross-sectional study","volume":"35","author":"Oguz","year":"2016","journal-title":"Clin Rheumatol"},{"key":"2018112909385360000_45.8.1153.12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1843.2006.00834.x"},{"key":"2018112909385360000_45.8.1153.13","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2796.2006.01704.x"},{"key":"2018112909385360000_45.8.1153.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2014.04.009"},{"key":"2018112909385360000_45.8.1153.15","doi-asserted-by":"publisher","DOI":"10.1007\/s00408-013-9530-0"},{"key":"2018112909385360000_45.8.1153.16","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.resinv.2016.09.003","article-title":"Prognostic value of serial serum KL-6 measurements in patients with idiopathic pulmonary fibrosis","volume":"55","author":"Wakamatsu","year":"2017","journal-title":"Respir Investig"},{"key":"2018112909385360000_45.8.1153.17","doi-asserted-by":"publisher","DOI":"10.1159\/000018382"},{"key":"2018112909385360000_45.8.1153.18","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.080633"},{"key":"2018112909385360000_45.8.1153.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2013.03.015"},{"key":"2018112909385360000_45.8.1153.20","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00004711"},{"key":"2018112909385360000_45.8.1153.21","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.120997"},{"key":"2018112909385360000_45.8.1153.22","doi-asserted-by":"publisher","DOI":"10.1002\/art.22559"},{"key":"2018112909385360000_45.8.1153.23","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00131713"},{"key":"2018112909385360000_45.8.1153.24","doi-asserted-by":"publisher","DOI":"10.1002\/art.21257"}],"container-title":["The Journal of Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.3899\/jrheum.170518","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,11,29]],"date-time":"2018-11-29T19:27:52Z","timestamp":1543519672000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jrheum.org\/lookup\/doi\/10.3899\/jrheum.170518"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,1]]},"references-count":24,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2018,8,1]]},"published-print":{"date-parts":[[2018,8]]}},"alternative-id":["10.3899\/jrheum.170518"],"URL":"https:\/\/doi.org\/10.3899\/jrheum.170518","relation":{},"ISSN":["0315-162X","1499-2752"],"issn-type":[{"value":"0315-162X","type":"print"},{"value":"1499-2752","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,1]]}}}